The round was led by FCA Venture Partners, with the Labcorp Venture Fund and Epsilon anchoring the final close as the primary investors. Strong participation also came from existing investors, ...

Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting ...

OPKO Health recently reported third-quarter earnings with revenue of US$151.67 million and net income of US$21.63 million, surpassing analyst expectations, and announced a collaboration with Regeneron ...

The company's presence highlights Dublin’s growing reputation as a destination for innovation, connectivity and business ...

The Dublin-based firm is developing an array of artificial intelligence-derived tools to improve the efficiency of its digital pathology outsourcing service.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Labcorp Holdings yesterday and set a price target of $280.00. The company’s shares closed yesterday at $248.14. Take advantage of ...

Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from the third quarter of 2025 and recent ...

Laboratory services provider Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a ...

Q3 2025 Earnings Call Transcript October 28, 2025 Labcorp Holdings Inc. beats earnings expectations. Reported EPS is $4.18, ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q3 CY2025, with sales up ...